Table 1.
Demographics | N (%) |
---|---|
Number (N) | 115 (100) |
Median age - years (range) | 71.3 (29.4 – 92.4) |
Race | |
Caucasian | 115 (100) |
AJCC stage | |
IIIc | 7 (6) |
M1a | 6 (5) |
M1b | 10 (9) |
M1c | 89 (77) |
Not recorded | 3 (3) |
Mutational status | |
BRAF V600 mutated | 28 (24) |
NRAS mutations* | 24 (25) |
Prior systemic treatment for metastatic disease | |
No prior treatment | 41 (36) |
Ipilimumab | 59 (51) |
Dabrafenib and Trametinib | 18 (16) |
Chemotherapy | 13 (11) |
*Documented in 95 patient.